Insider trading

Period: 120 months Stock: ADPT + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

570 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

570 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

570 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

570 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
570 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
570 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

570 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Jun 2020
BENZENO SHARON Chief Business Development Off
Sold, plan not stated
$270.80K 6,770 at 40.00
100%
Sold half or more
3 Jun 2020
DOBMEIER ERIC Director
Sold, plan not stated
$198.95K 5,000 at 39.79
100%
Sold half or more
26 May 2020
Taylor Stacy L SVP and General Counsel
Sold, plan not stated
$120.96K 2,880 at 42.00
68.9%
Sold half or more
26 May 2020
BENZENO SHARON Chief Business Development Off
Sold, plan not stated
$17.47K 416 at 42.00
100%
Sold half or more
21 May 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$2.01M 50,000 at 40.29
2.6%
20 May 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$2.02M 50,000 at 40.46
2.6%
20 May 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated
$1.27M 31,372 at 40.48
97.9%
Sold half or more
19 May 2020
BENZENO SHARON Chief Business Development Off
Sold, plan not stated
$9.87M 246,770 at 40.00
100%
Sold half or more
19 May 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated
$2.00M 50,000 at 40.00
98.0%
Sold half or more
19 May 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated 2×
$2.00M 50,000 at 39.94
2.6%
19 May 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated
$1.55M 38,628 at 40.11
54.7%
Sold half or more
19 May 2020
DOBMEIER ERIC Director
Sold, plan not stated
$200.00K 5,000 at 40.00
100%
Sold half or more
18 May 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$436.48K 11,100 at 39.32
13.6%
15 May 2020
SANG CHARLES SVP, Clinical Diagnostics
Sold, plan not stated
$1.52M 40,000 at 38.01
100%
Sold half or more
15 May 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 5×
$1.32M 35,400 at 37.43
33.4%
15 May 2020
HERSHBERG ROBERT Director
Sold, plan not stated 3×
$69.50K 2,000 at 34.75
100%
Sold half or more
14 May 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$1.10M 31,200 at 35.32
30.6%
12 May 2020
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$1.15M 30,000 at 38.36
100%
Sold half or more
11 May 2020
RUBINSTEIN JULIE President
Sold, plan not stated
$3.04M 80,000 at 38.00
100%
Sold half or more
8 May 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated
$718.40K 20,000 at 35.92
95.2%
Sold half or more
7 May 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated 2×
$1.60M 45,000 at 35.60
2.3%
7 May 2020
DOBMEIER ERIC Director
Sold, plan not stated
$175.00K 5,000 at 35.00
100%
Sold half or more
6 May 2020
BALDO LANCE Chief Medical Officer
Sold, plan not stated 2×
$1.69M 50,000 at 33.86
100%
Sold half or more
27 Apr 2020
Taylor Stacy L SVP and General Counsel
Sold, plan not stated
$591.71K 19,580 at 30.22
93.8%
Sold half or more
23 Apr 2020
HERSHBERG ROBERT Director
Sold, plan not stated
$744.25K 25,000 at 29.77
100%
Sold half or more
22 Apr 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$775.10K 25,600 at 30.28
26.6%
21 Apr 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$113.91K 3,900 at 29.21
5.2%
20 Apr 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 3×
$429.51K 14,900 at 28.83
17.4%
20 Apr 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated
$300.00K 10,000 at 30.00
90.9%
Sold half or more
15 Apr 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$300.97K 10,620 at 28.34
0.6%
15 Apr 2020
ROBINS CHAD M CEO and Chairman
Bought
$13.81K 500 at 27.62
0.0%
First buy on file
14 Apr 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$940.75K 33,360 at 28.20
1.7%
13 Apr 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated 3×
$144.80K 5,560 at 26.04
0.3%
8 Apr 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated 2×
$367.03K 15,000 at 24.47
93.8%
Sold half or more
20 Mar 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated 3×
$127.26K 5,560 at 22.89
0.3%
19 Mar 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$247.98K 11,120 at 22.30
0.6%
10 Mar 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated
$69.01K 2,700 at 25.56
73.0%
Sold half or more
9 Mar 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated 2×
$299.67K 12,300 at 24.36
92.5%
Sold half or more
21 Feb 2020
RUBINSTEIN JULIE President
Sold, plan not stated
$167.75K 5,000 at 33.55
100%
Sold half or more
20 Feb 2020
RUBINSTEIN JULIE President
Sold, plan not stated 2×
$2.69M 80,000 at 33.57
100%
Sold half or more
20 Feb 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$247.58K 7,400 at 33.46
9.5%
19 Feb 2020
RUBINSTEIN JULIE President
Sold, plan not stated
$2.64M 80,000 at 33.00
100%
Sold half or more
19 Feb 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated 2×
$242.15K 7,400 at 32.72
9.5%
18 Feb 2020
ROBINS HARLAN S Chief Scientific Officer
Sold, plan not stated
$580.53K 18,500 at 31.38
20.7%
13 Feb 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$350.95K 11,120 at 31.56
0.6%
12 Feb 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$348.06K 11,120 at 31.30
0.6%
11 Feb 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$346.72K 11,120 at 31.18
0.6%
10 Feb 2020
Cohen Chad M Chief Financial Officer
Sold, plan not stated 2×
$630.31K 20,000 at 31.52
95.2%
Sold half or more
29 Jan 2020
ROBINS CHAD M CEO and Chairman
Sold, plan not stated
$344.61K 11,120 at 30.99
0.6%
28 Jan 2020
VIKING GLOBAL PERFORMANCE LLC 10% owner · indirect
Sold, plan not stated
$122.71M 4,912,899 at 24.98
12.8%
Showing 501–550 of 570. ← Newer Page 11 of 12 Older →